Should patients with hepatitis C genotype 2/3 infection who are slow responders to pegylated interferon/ribavirin have treatment duration extended?

Carla Silva, Elizabeth Ianna, Tracey Jones, Joshua Davis

    Research output: Contribution to journalComment/debate

    Abstract

    [No abstract available]
    Original languageEnglish
    Pages (from-to)660-661
    Number of pages2
    JournalHepatology
    Volume62
    Issue number2
    DOIs
    Publication statusPublished - Aug 2015

    Fingerprint Dive into the research topics of 'Should patients with hepatitis C genotype 2/3 infection who are slow responders to pegylated interferon/ribavirin have treatment duration extended?'. Together they form a unique fingerprint.

  • Cite this